During the past decade, John Muir Physician Network Clinical Research Center conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 20 clinical trials were completed, i.e. on average, 64.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 13 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Muir Physician Network Clinical Research Center" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "AstraZeneca" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Evoke Pharma" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Muir Physician Network Clinical Research Center" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "John Muir Physician Network Clinical Research Center" are "Diabetes Mellitus, Type 2" (7 trials), "Type 2 Diabetes Mellitus" (6 trials), "Type 1 Diabetes Mellitus" (4 trials), "Diabetes Mellitus, Type 1" (3 trials) and "Obesity" (3 trials). Many other conditions were trialed in "John Muir Physician Network Clinical Research Center" in a lesser frequency.

Most popular intervention types in "John Muir Physician Network Clinical Research Center" are "Drug" (36 trials), "Device" (6 trials), "Other" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Insulin Degludec" (5 trials), "Tirzepatide" (3 trials), "Continuous Glucose Monitoring System" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "John Muir Physician Network Clinical Research Center" are 43 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "John Muir Physician Network Clinical Research Center". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in John Muir Physician Network Clinical Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in John Muir Physician Network Clinical Research Center, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".